PRISM was established in 2008 by Akram Khan, MD (MBBS) as the principal investigator to advance research to improve patient outcomes in Acute Respiratory Distress Syndrome and Sepsis.

PRISM research team performs phase II-IV clinical trials in pulmonary clinics and hospital settings. We have multiple ongoing clinical trials in conditions such as COPD, COVID-19, and Acute Respiratory Distress Syndrome.